Eiger BioPharmaceuticals2018-03-13T10:47:27+00:00

IN THE NEWS

Eiger BioPharmaceuticals to Host R&D Day in New York City

December 4th, 2018|

Eiger BioPharmaceuticals to Host R&D Day in New York City PALO ALTO, Calif., December 4, 2018 – Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced it will host an R&D Day on December 11, 2018 from 12:00 PM to 2:30 PM EST at the St. Regis Hotel in New York City. Eiger management will discuss all programs in its late stage pipeline, including clinical and regulatory program updates, [...]

Eiger BioPharmaceuticals Announces FDA Acceptance of IND Application for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies

December 3rd, 2018|

Eiger BioPharmaceuticals Announces FDA Acceptance of IND Application for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies Plans to File NDA in 2019PALO ALTO, Calif., December 3, 2018 — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for lonafarnib in the treatment of both Hutchinson-Gilford Progeria Syndrome (HGPS or progeria) and [...]

Eiger BioPharmaceuticals Announces the Appointment of Sri Ryali as Chief Financial Officer

December 3rd, 2018|

Eiger BioPharmaceuticals Announces the Appointment of Sri Ryali as Chief Financial Officer PALO ALTO, Calif., December 3, 2018 — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced the appointment of Sri Ryali as the company’s Chief Financial Officer.  Mr. Ryali brings over fifteen years of finance and commercial experience to Eiger.  He was most recently at Aimmune Therapeutics, Inc., where he was Vice President of Finance, responsible for [...]